COPD Trial, Recruiting NCT02779478 Sponsor: NYU Langone Health Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT02779478
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have experienced lung-related symptoms such as cough, tiredness, general feeling of being unwell, fever, unexplained weight loss, shortness of breath, coughing up blood, or chest discomfort.
  • People who have had an abnormal chest X-ray or CT scan within the past 2 years, showing specific findings such as nodules, cavities, or signs of airway damage with small nodules.
  • People whose test results show a type of bacteria called NTM (non-tuberculous mycobacteria) found in at least two separate sputum (mucus) samples, or in one sample taken during a lung washout procedure or lung biopsy (this group is classed as an "NTM case").
  • People whose test results do NOT show NTM bacteria in sputum samples or lung samples, but who still have symptoms and imaging findings as described above (this group is classed as an "NTM control").

Who may not be able to join:

  • People who have taken antibiotic or steroid medications by mouth within the past month (note: long-term use of a specific type of antibiotic called macrolides, or inhaled steroids used for more than one month, may still be acceptable — confirm with trial site).
  • People who have smoked recently.
  • People whose lung function test results show reduced breathing capacity below a certain level (confirm with trial site — this applies to the bronchoscopy part of the study only).
  • People with significant heart problems, including an abnormal heart tracing (ECG), known or suspected heart disease, or heart failure (bronchoscopy part only).
  • People who have diabetes (bronchoscopy part only).
  • People with significant liver or kidney disease (bronchoscopy part only).
  • People with serious blood clotting problems, based on specific blood test results (bronchoscopy part only).
  • People who are pregnant (bronchoscopy part only).
  • People who drink more than 6 beers or more than 4 mixed alcoholic drinks per day (bronchoscopy part only).
  • People who are not able to give informed consent to take part in the study (bronchoscopy part only).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 October 2014
Est. completion
1 July 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Evaluation of airway microbiome in subjects with active pulmonary NTM disease and compare with controls

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov